Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq analysis of myeloid cells in dLNs post-administration of mRNA vaccine

ABSTRACT: RNA-seq analysis of myeloid cells in dLNs post-administration of mRNA vaccine

PROVIDER: PRJNA1001335 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25492810_1.fastq.gz	Fastqsanger.gz
	SRR25492810_2.fastq.gz	Fastqsanger.gz
	SRR25492811_1.fastq.gz	Fastqsanger.gz
	SRR25492811_2.fastq.gz	Fastqsanger.gz
	SRR25492812_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

RNA-seq analysis of myeloid cells in dLNs post-administration of mRNA vaccine

Project description:To investigate transcriptional signatures of myeloid cells in dLNs post-administration of mRNA vaccine, we collected dLNs from mice 24 h post-vaccination, sorted six types of myeloid subsets using FACS, and performed RNA-seq analysis. RNA-seq data showed increased expression of markers related to proinflammation and antigen presentation throughout myeloid subsets in dLNs post-administration of the mRNA vaccine.

2024-01-25 | GSE239881 | GEO

Whole blood transcriptional analysis of vaccine combination administration in infants

Project description:We aimed to identify the gene network and pathway biology associated with response to vaccine administration by determining genome-wide alterations in host RNA in children Samples were obtained from children before and after vaccine administration. RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.

2016-07-20 | E-GEOD-83951 | biostudies-arrayexpress

Whole blood transcriptional analysis of vaccine combination administration in infants

Project description:We aimed to identify the gene network and pathway biology associated with response to vaccine administration by determining genome-wide alterations in host RNA in children

2016-07-20 | GSE83951 | GEO

Effect of vaccine administration routes on responses to a Bordetella pertussis outer membrane vesicle vaccine - lung

Project description:Pulmonary immunization with an outer membrane vesicle pertussis vaccine led to improved protection and induction of a completely distinct immune response compared to subcutaneous administration. These adaptive responses were linked to early local and systemic signatures on the transcriptome level.

2017-09-21 | GSE83602 | GEO

Effect of vaccine administration routes on responses to a Bordetella pertussis outer membrane vesicle vaccine - lymph nodes

2017-09-21 | GSE83603 | GEO

Transcriptome atlas of injection site response reveals initial mechanisms of mRNA vaccine immunity

Project description:Precise immunological mechanisms of mRNA vaccines have still not been fully elucidated, especially the initial immune responses at the injection site. Here, by constructing a single-cell atlas of injection site responses of mRNA vaccine, we show that stromal inflammatory responses and type I interferon responses dominate initial transcriptional reactions elicited by mRNA vaccines at the injection site. Tracking down the fates of the delivered mRNA revealed that injection site fibroblasts are highly enriched with the delivered mRNA, and they express IFN-β specifically in response to the mRNA component, not to the LNP. Accordingly, migratory dendritic cells highly expressing interferon stimulated genes (mDC_ISG) were found specifically in muscle and draining lymph nodes of mRNA vaccine injected mice, compared to the empty LNP injected mice. Co-administration of IFN-β and LNP robustly induced mDC_ISGs at the injection site and substantially enhanced antigen-specific CD8 T cell responses. Collectively, these data elucidate earliest mechanisms of the mRNA vaccine and highlight the underappreciated immunogenic role of the mRNA component in the mRNA vaccine.

2023-12-14 | GSE239574 | GEO

Immune transcriptome in adult-onset Still’s disease with mild flare following administration of mRNA vaccine BNT162b2

Project description:Immune transcriptome in adult-onset Still’s disease with mild flare following administration of mRNA vaccine BNT162b2

| PRJNA815866 | ENA

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms

Project description:A single arm, open-label pilot study is designed to determine the safety, tolerability and effectiveness of personalized mRNA tumor vaccine encoding neoantigen in Patients with advanced esophageal squamous carcinoma, gastric adenocarcinoma, pancreatic adenocarcinoma and colorectal adenocarcinoma

| 2268561 | ecrin-mdr-crc

Immunopeptidomics-based design of highly effective mRNA vaccine formulations against Listeria monocytogenes

Project description:Listeria monocytogenes is a foodborne intracellular bacterial pathogen leading to human listeriosis. Despite a high mortality rate and increasing antibiotic resistance no clinically approved vaccine against Listeria is available. To identify antigens for this bacterial pathogen that can be encoded in mRNA vaccine formulations, we screened for Listeria epitopes presented on the surface of infected human cell lines by mass spectrometry-based immunopeptidomics. In between more than 15,000 human self-peptides, we detected 68 Listeria epitopes from 42 different bacterial proteins, including several known antigens. Peptide epitopes presented on different cell lines were often derived from the same bacterial surface proteins, classifying these antigens as potential vaccine candidates. Encoding these highly presented antigens in lipid nanoparticle mRNA vaccine formulations resulted in high levels of protection in vaccination challenge experiments in mice. Our results pave the way for the development of a clinical mRNA vaccine against Listeria and demonstrate the power of immunopeptidomics for next-generation bacterial vaccine development.

2022-09-26 | PXD031451 | Pride

Effect of vaccine administration routes on responses to a Bordetella pertussis outer membrane vesicle vaccine

Project description:Effect of vaccine administration routes on responses to a Bordetella pertussis outer membrane vesicle vaccine

| PRJNA326476 | ENA